Clinics asked to check drugs for meningitis risk
The Minnesota Department of Health determined that 129 clinics in Minnesota received injectable drugs from New England Compounding Center that could pose a potential risk of meningitis or other infections to their patients.
Staff from MDH are in the process of contacting those clinics to make sure that they are contacting their patients who were given the drugs and instructing them to see their health care provider if they develop symptoms of meningitis.
Are you a newspaper subscriber but you don't have a Digital Access account yet? https://secure.forumcomm.com/?publisher_ID=40&event=subscriber/lookup.
You will need your subscription account number and phone number. Not sure if you have an account? Email us at email@example.com and we can help you.